baber/WOPTO huggingface dataset:
Patent AU-2008242692-B2 (AU)
Title: Improved flow valve port for a gas regulator
Inventor: QUIJANO ERIK M
IPC: G05D16/06
Filed: 2008-04-18
Granted: 2011-10-20
Abstract: A fluid regulating device comprises a valve body carrying a valve port that defines an elongated orifice that converges from an inlet portion to an outlet portion. The converging orifice minimizes the effects of boundary layer separation and advantageously maximizes the flow capacity of the valve port. The elongated orifice can be defined by a one-piece body, which is threaded into the valve body, or by a cartridge slidably disposed in a housing, which is threaded into the valve body. The fluid regulating device further comprises a diaphragm-based actuator including a control element movably disposed within the valve body for controlling the flow of fluid therethrough.
Patent AU-2008244164-B2 (AU)
Title: Coupling arrangement for coupling rock drill shank
Inventor: ESKO MAURI
IPC: F16D3/44
Filed: 2008-04-24
Granted: 2012-05-10
Abstract: The invention relates to a coupling arrangement for coupling a drill shank (3) of a rock drill unrotatably but axially movably. The coupling arrangement comprises power transmission members (8; 8a, 8b) between the surfaces of the drill shank (3) and the rotation bushing (6), which transmission members rotate along the surfaces, as the drill shank (3) moves longitudinally to the rotation bushing (6), and transmit the rotation torque from the rotation bushing (6) to the drill shank (3).
Patent AU-2008255134-B2 (AU)
Title: Anatomical modeling from a 3-D image and a surface mapping
Inventor: ALTMANN ANDRES CLAUDIO
IPC: A61B8/13
Filed: 2008-12-04
Granted: 2014-03-27
Abstract: -35 A method of medical imaging includes creating an anatomical map of an inner wall of a cavity in a body of a subject by inserting a probe into the body and collecting 5 data using the probe. A three dimensional (3-D) contour is delineated in a 3-D image of the cavity based on the map. 04/12/08,va 17628 spcci.35 Co w C4 CA C4 C4 C) cc c-cn co1
Patent AU-2008264991-B2 (AU)
Title: Monitoring an immunoassay
Inventor: BROOKES DAVID PATRICK EDWARD
IPC: G01N33/557
Filed: 2008-06-19
Granted: 2013-08-29
Abstract: A method of monitoring an immunoassay comprises determining the position of the flow edge of fluid across an immunoassay region. This allows, for example, early detection of possible errors in the test. For example the speed of the movement of the fluid flow edge may be determined from measurements of the position of the fluid flow edge at times throughout the test, and the determined speed may be compared with one or more thresholds to determine whether the test is proceeding correctly. A further method of monitoring an immunoassay comprising monitoring the variation with time of a reference zone of an immunoassay region. This can provide the user with early information as to whether the test is proceeding correctly. The above methods may also be used to provide methods to improve the run conditions of a test during its development. The method may be applied to a competitive assay.
Patent AU-2008270209-B2 (AU)
Title: dsRNA for treating viral infection
Inventor: LABOW MARK ARON
IPC: A61K31/713
Filed: 2008-07-04
Granted: 2012-05-17
Abstract: The invention relates to double-stranded ribonucleic acids (dsRNAs) targeting gene expression of phosphatidylinositol 4-kinase (PI4K), in particular human phosphatidylinositol 4-kinase, catalytic, beta polypeptide (PIK4CB) or human phosphatidylinositol 4-kinase, catalytic, alpha polypeptide (PIK4CA), and their use for treating infection by positive stranded RNA viruses such as hepatitis C virus (HCV). Each dsRNA comprises an antisense strand having a nucleotide sequence which is less that 30 nucleotides in length, generally 19-25 nucleotides in length, and which is substantially complementary to at least a part of the PIK4CB or PIK4CA target mRNA. A plurality of such dsRNA may be employed to provide therapeutic benefit. The invention also relates to a pharmaceutical composition comprising the dsRNA together with a pharmaceutically acceptable carrier, and including a delivery modality such as fully encapsulated liposomes or lipid complexes.
Patent AU-2008290202-B2 (AU)
Title: Irrigation control system
Inventor: SHANI URI
IPC: A01G25/16
Filed: 2008-08-05
Granted: 2012-11-01
Abstract: A tensiometer for use in determining matric potential of a soil comprising: a water inlet; a hydraulic coupler comprising a porous material for providing hydraulic coupling between water that enters the inlet and the soil; and a septum that seals water that enters the inlet against ingress of air via the porous material.
Patent AU-2008311334-B2 (AU)
Title: Hybrid wireless/wired transponder and hybrid radio-over-fiber communication system using same
Inventor: ZENTENO LUIS A
IPC: H04B10/12
Filed: 2008-09-19
Granted: 2012-09-20
Abstract: A radio-over-fiber (RoF) hybrid wired/wireless transponder is disclosed that is configured to provide both wireless and wired communication between a hybrid head-end and one or more client devices. The hybrid transponder includes optical-to-electrical (O/E) and electrical-to-optical (E/O) conversion capability and is configured to frequency multiplex/demultiplex electrical "wired" signals and electrical "wireless" signals. The electrical wireless signals are wirelessly communicated to the client device(s) via a multiple- input/multiple-output (MIMO) antenna system within a cellular coverage area. The electrical wired signals are communicated to the client device(s) via a wireline cable that plugs into a wireline cable port on the transponder. The hybrid RoF system includes a hybrid head-end capable of transmitting and receiving wired and wireless optical signals, and an optical fiber cable that is optically coupled to the hybrid head-end and to at least one hybrid transponder. Drop-down transponder configurations that allow for easy wired and wireless connectivity between the client device(s) to the transponder(s) are also disclosed.
Patent AU-2008339095-B2 (AU)
Title: Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9H-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy
Inventor: SCHULZ HAKAN
IPC: A61P11/00
Filed: 2008-12-16
Granted: 2012-05-03
Abstract: The present invention concerns hydrochloric acid, hydrobromic acid and maleic acid salts of methyl (3-{ [ [3- (6-amino-2- butoxy-8-oxo-7, 8-dihydro-9H-purin-9-yl) propyl] (3-morpholin-4- ylpropyl) amino] methyl} phenyl) acetate, compositions comprising them and their use in therapy.
Patent AU-2008340311-B2 (AU)
Title: Cannula
Inventor: TORRIE PAUL ALEXANDER
IPC: A61B17/02
Filed: 2008-12-17
Granted: 2014-12-18
Abstract: The present disclosure relates to a cannula. The cannula includes a shaft having a distal end and a proximal end and a handle coupled to the proximal end of the shaft. The distal end of the shaft includes a tip having a spherical radius.
Patent AU-2009200839-B2 (AU)
Title: Foldable pushcart and foldable baby carriage
Inventor: OHNISHI ICHIRO
IPC: B62B1/04
Filed: 2009-03-04
Granted: 2013-07-04
Abstract: A baby carriage includes: a pair of front legs; a pair of connecting members; a pair of guide sleeves respectively fixed to intermediate regions of the pair of front legs, a pair of rear legs having their upper ends pivotally 5 connected to the connecting members, respectively; a pair of push bars slidably held by the pair of connecting members and the pair of guide sleeves, respectively; a pair of slide members provided slidably on upper regions of the pair of rear legs, respectively; a back cross member having its upper end pivotally connected to the pair of slide members and its lower end 10 pivotally connected to respective lower regions of the pair of rear legs; and a bottom cross member having its front end pivotally connected to respective lower ends of the pair of push bars, and its rear end pivotally connected to respective intermediate regions of the pair of rear legs.
Patent AU-2009201731-B2 (AU)
Title: Washing machine having washing course for shoes
Inventor: KIM HYUNG YONG
IPC: A47L23/00
Filed: 2009-04-28
Granted: 2010-12-02
Abstract: The present invention relates to washing machines, and, more particularly, to a washing machine in which a drum that holds laundry is rotated with respect to a substantially horizontal rotation shaft.  The washing machine includes a shoe course selection unit for enabling a user to select a shoe course, and a controller for controlling operation of the washing machine to wash shoes while swinging the drum within 90° in left/right directions if the user selects the shoe course.
Patent AU-2009215667-B2 (AU)
Title: Syngas conversion system using asymmetric membrane and anaerobic microorganism
Inventor: DATTA RATHIN
IPC: C12P7/04
Filed: 2009-02-11
Granted: 2014-01-16
Abstract: A stable system for producing liquid products such as ethanol, butanol and other chemicals from syngas components contacts CO or a mixture of CO
Patent AU-2009223702-B2 (AU)
Title: Labeled reactants and their uses
Inventor: WEGENER JEFFREY
IPC: G01N33/532
Filed: 2009-03-12
Granted: 2013-08-22
Abstract: Labeled reactant compositions, and particularly labeled nucleic acid reaction compositions, that include structural components that maintain potentially damaging labeling components sufficiently distal from the reactant portion of the molecule such that damaging effects of the label group on other reaction components, such as enzymes, are reduced, minimized and/or eliminated.
Patent AU-2009227925-B2 (AU)
Title: Use of effectors of glutaminyl and glutamate cyclases
Inventor: NIESTROJ ANDRE J
IPC: C07F9/572
Filed: 2009-10-23
Granted: 2011-12-15
Abstract: The present invention provides novel physiological substrates of mammalian glutaminyl cyclase (QC, EC 2.3.2.5), new effectors of QC, methods for screening for such effectors, and the use of such effectors and pharmaceutical compositions comprising such effectors for the treatment of conditions that can be treated by modulation of QC-activity. Preferred compositions additionally comprise inhibitors of DP IV or DP IV-like enzymes for the treatment or alleviation of conditions that can be treated by modulation of QC- and DP IV-activity.
Patent AU-2009270482-B2 (AU)
Title: Data carrier comprising a printed variably magnetic security feature
Inventor: SCHUTZMANN JURGEN
IPC: B41M3/14
Filed: 2009-07-14
Granted: 2013-08-01
Abstract: The invention relates to a method for producing a data carrier (1) comprising a printed security feature (3), said method comprising the following steps: (a) printing ink is printed onto the data carrier for producing at least part of the security feature, the printing ink containing a magnetic substance, and (b) the quantity of magnetic substance is reduced in at least some of the printed printing ink.
Patent AU-2009273197-B2 (AU)
Title: 3,4-diarylpyrazoles as protein kinase inhibitors
Inventor: PULICI MAURIZIO
IPC: A61P35/00
Filed: 2009-07-23
Granted: 2014-01-16
Abstract: 3,4-diarylpyrazole derivatives of formula (I) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
Patent AU-2009279868-B2 (AU)
Title: Side reinforced railway brake shoe
Inventor: FORMOLO JOSEPH F
IPC: F16D65/04
Filed: 2009-07-29
Granted: 2013-09-19
Abstract: A molded brake shoe formed of friction material with or without a metal backing. Along at least a portion of at least one side surface of the brake shoe there is a layer of the molded friction material reinforced with a fiber.
Patent AU-2009288162-B2 (AU)
Title: Indirect-error-based, dynamic upscaling of multi-phase flow in porous media
Inventor: LEE SEONG H
IPC: G06F11/00
Filed: 2009-09-01
Granted: 2015-07-02
Abstract: Computer-implemented systems and methods are provided for an upscaling approach based on dynamic simulation of a given model. A system and method can be configured such that the accuracy of the upscaled model is continuously monitored via indirect error measures. If the indirect error measures are bigger than a specified tolerance, the upscaled model is dynamically updated with approximate fine-scale information that is reconstructed by a multi-scale finite volume method. Upscaling of multi-phase flow can include flow information in the underlying fine-scale. Adaptive prolongation and restriction operators are applied for flow and transport equations in constructing an approximate fine-scale solution.
Patent AU-2009310952-B2 (AU)
Title: Novel amide derivative and use thereof as medicine
Inventor: ISHIBUCHI SEIGO
IPC: C07D413/12
Filed: 2009-10-27
Granted: 2015-04-30
Abstract: A novel low molecular weight compound which inhibits the production of inducible MMPs, particularly MMP-9, rather than the production of constitutive MMP-2 is provided, and furthermore, a preventive/therapeutic agent for an autoimmune disease or osteoarthritis is provided.  An amide derivative represented by formula (I) (wherein the respective symbols are as defined in the description), a pharmacologically acceptable salt thereof, or a hydrate or solvate thereof.
Patent AU-2010209175-B2 (AU)
Title: Drainless air conditioner
Inventor: ISHIMOTO SHINJI
IPC: F24F11/02
Filed: 2010-01-28
Granted: 2012-11-01
Abstract: An air conditioning device, wherein latent heat and sensible heat are processed by the device alone, the device can be manufactured and installed at reduced costs, and the device can be operated with reduced energy. A drainless air conditioning device (10) using mixed air for air conditioning, the mixed air being a mixture of a part of indoor air (RA) and outside air (OA). A first adsorption heat exchanger (51) and a second adsorption heat exchanger (52) can regulate the humidity of air. An air heat exchanger (60) can exchange heat between air and fluid having been heat treated by a heat source. After the humidity of outside air is processed by the first adsorption heat exchanger (51) or the second adsorption heat exchanger (52), the outside air is mixed with a part of the indoor air (RA) to be mixed air. The mixed air is subjected to heat exchange with cold water or warm water by the indoor heat exchanger (60). Exhaust air (EA) is sent outdoors after the humidity thereof is processed by the first adsorption heat exchanger (51) or the second adsorption heat exchanger (52).
Patent AU-2010244131-B2 (AU)
Title: Generic assays for detection of influenza viruses
Inventor: ROTH BERNHARD
IPC: C12Q1/70
Filed: 2010-05-10
Granted: 2014-03-13
Abstract: The invention relates to generic methods for the detection and quantification of influenza viruses. These may uses a reverse transcription (RT-PCR) real time (q-PCR) assay which amplifies a conserved region within influenza A or B strains. The assays allow the quantification of influenza virus RNA molecules or whole virus particles, irrespective of the particular virus strain (e.g. human, avian, swine flu). The methods are particularly applicable as diagnostic assays or in the monitoring of vaccine production processes.
Patent AU-2010244581-B2 (AU)
Title: Insecticidal compounds
Inventor: MAIENFISCH PETER
IPC: C07C255/57
Filed: 2010-04-14
Granted: 2015-09-17
Abstract: The present invention relates to bis-amide derivatives of formula (I), to processes and intermediates for preparing them, to methods of using them to control insect, acarine, nematode and mollusc pests, and to insecticidal, acaricidal, nematicidal and molluscicidal compositions comprising them.
Patent AU-2010255638-B2 (AU)
Title: Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections
Inventor: DEPLA ERIK
IPC: C07K16/10
Filed: 2010-06-07
Granted: 2014-10-16
Abstract: Amino acid sequences are provided that are directed against and/or that can specifically bind protein F of hRSV, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences. The amino acid sequences, polypeptides and therapeutic compounds and compositions provided by the invention show an improved stability, less immunogenicity and/or improved affinity and/or avidity for protein F of hRSV. The invention also relates to the uses of such amino acid sequences, polypeptides, compounds or constructs for prophylactic and/or therapeutic purposes.
Patent AU-2010266533-B2 (AU)
Title: Analyte monitoring device and methods of use
Inventor: HELLER ADAM
IPC: G01N27/26
Filed: 2010-06-26
Granted: 2014-03-27
Abstract: In aspects of the present disclosure, a no coding blood glucose monitoring unit including a calibration unit is integrated with one or more components of an analyte monitoring system to provide compatibility with in vitro test strip that do not require a calibration code is provided. Also disclosed are methods, systems, devices and kits for providing the same.
Patent AU-2010303414-B2 (AU)
Title: Methods and compositions for skin regeneration
Inventor: MIZE NANCY
IPC: A61K38/18
Filed: 2010-10-07
Granted: 2016-01-07
Abstract: Compositions and methods for inducing tissue differentiation and growth within a localized area of application in humans or other animals are provided. Compositions comprising a biological or pharmacologically active agent such as Insulin-like Growth Factor-1 (IGF-1) and sustained-release nanoparticle formulations comprising IGF-1 and a matrix forming component such as hyaluronan for use in skin repair and regeneration are provided. Nanoparticles of the invention activate endogenous stem cells in the local area of administration to produce new dermal cells and tissues.
Patent AU-2010324757-B2 (AU)
Title: Targeted binding agents against B7-H1
Inventor: QUEVA CHRISTOPHE
IPC: C07K16/28
Filed: 2010-11-24
Granted: 2016-03-17
Abstract: Human monoclonal antibodies directed against B7-H1 and uses of these antibodies in diagnostics and for the treatment of diseases associated with the activity and/or expression of B7-H1 are disclosed. Additionally, hybridomas or other cell lines expressing such antibodies are disclosed.
Patent AU-2010325202-B2 (AU)
Title: Electric drive system
Inventor: KARLSSON PONTUS
IPC: F16H48/22
Filed: 2010-10-14
Granted: 2015-05-28
Abstract: The present invention relates to an electric drive system comprising an electric motor (10) arranged to rotate a drive shaft (16); a drive planetary gear configuration (70) being in driving engagement with said drive shaft (16) and an output shaft (50) rotatable relative to said drive shaft (16); and means for providing change in rotational speed of said output shaft (50), wherein said rotational speed changing means (80, 82) are disposed on opposite sides of the motor (10) respectively. The present invention also relates to a motor driven unit, for example a motor vehicle.
Patent AU-2010335392-B2 (AU)
Title: Method and arrangement for a terminal of a wireless communication network
Inventor: LINDOFF BENGT
IPC: H04W48/08
Filed: 2010-11-26
Granted: 2014-01-09
Abstract: A method of operating a terminal of a wireless communication network is disclosed. The wireless communication network comprises one or more wireless network nodes having at least first and second downlink transmission modes, the first downlink transmission mode comprising normal operation of a particular network node and being applicable when a number of active terminals in a cell associated with the particular network node is greater than a first mode threshold value, and the second downlink transmission mode comprising restricted downlink transmission of the particular network node and being applicable when the number of active terminals in the cell associated with the particular network node is less than or equal to a second mode threshold value. The method comprises detecting a cell identity for a cell associated with a wireless network node of the wireless communication system, detecting a current downlink transmission mode of the wireless network node as the first or second downlink transmission mode, and adapting a further operation of the terminal based on the detected current downlink transmission mode. Corresponding computer program product and arrangement are also disclosed.
Patent AU-2010345902-B2 (AU)
Title: Wireless communication apparatus, wireless communication system and wireless communication method
Inventor: OHTA YOSHIAKI
IPC: H04W72/04
Filed: 2010-02-12
Granted: 2015-06-04
Abstract: Using a plurality of frequency bands can be efficiently controlled. Wireless communication apparatuses (1, 2) communicate with each other using a plurality of frequency bands. During a random access procedure, the wireless communication apparatus (1) uses a first frequency band to transmit a control message, which includes identification information indicating a second frequency band different from the first frequency band, to the wireless communication apparatus (2). The wireless communication apparatus (2) receives the control message transmitted by use of the first frequency band from the wireless communication apparatus (1) and uses the second frequency band, which is indicated by the identification information included in the control message, to perform data communications.
Patent AU-2011200752-B2 (AU)
Title: Method and system to allow for high DC source voltage with lower DC link voltage in a two stage power converter
Inventor: WAGONER ROBERT GREGORY
IPC: H02M7/00
Filed: 2011-02-22
Granted: 2013-03-07
Abstract: METHOD AND SYSTEM TO ALLOW FOR HIGH DC SOURCE VOLTAGE WITH LOWER DC LINK VOLTAGE IN A TWO STAGE POWER CONVERTER 5 A system for supplying AC power from a DC power source, such as a photovoltaic array is disclosed. The system includes a converter and an inverter coupled by a DC link. Control methods and systems are provided to maintain the DC source voltage and the DC link voltage below the open-circuit voltage of the DC power source. During steady state conditions, the DC source voltage and the DC link voltage are maintained below the open 10 circuit voltage of the DC power source by controlling the output of the inverter. The DC link voltage is temporarily adjusted to allow for higher DC link transients when the DC power source is first coupled or re-coupled to the system. During conditions when the inverter is decoupled from the system, the converter is controlled to maintain the DC link voltage below the open-circuit voltage of the DC power source. 0 ' U0 0 U < >> 04 p oo Ccl
Patent AU-2011202873-B2 (AU)
Title: Composition for improving skin, hair and coat health containing flavanones
Inventor: RICHELLE MYRIAM
IPC: A23L1/00
Filed: 2011-06-15
Granted: 2013-05-23
Abstract: The present invention pertains to a composition for preventing, decreasing and/or treating skin and hair/coat disorders, such as is effected by inflammatory reactions, 5 environmental factors, ageing or cancer. In particular, the present invention relates to the use of flavanones compounds or their derivatives in nutritional, cosmetic or pharmaceutical compositions for improvement of human or pet animal skin and coat conditions.
Patent AU-2011205048-B2 (AU)
Title: Compounds and methods for the treatment or prevention of flavivirus infections
Inventor: DENIS REAL
IPC: C07D333/40
Filed: 2011-07-28
Granted: 2013-05-02
Abstract: Compounds represented by formula I: (I) z X R 5 2 y1 or pharmaceutically acceptable salts and solvates thereof, wherein R1, X, Y, Y1, and Z are as defined herein, are useful for treating flaviviridae viral infections.